Gorlin Steve's Form 4 filing
Biovie Inc. (BIVI) · filed Dec 6, 2023
- Accession no.
- 0001520138-23-000534
- Filed
- Dec 6, 2023
- Trade date
- Nov 9-Dec 1, 2023
- Filing delay
- 27 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $127.9K. It was filed 27 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorlin SteveCIK 0001033742 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | Common Stock | AGrant or awardAcquired | +46,358 | $0.00 | $0 | 122,038 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −75,680 | $1.69 | −$127,899.2 | 46,358 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.